Umeda Ryosuke, Ogata Soshiro, Hara Shigeo, Takahashi Kazuo, Inaguma Daijo, Hasegawa Midori, Yasuoka Hidetaka, Yuzawa Yukio, Hayashi Hiroki, Tsuboi Naotake
Department of Nephrology, Fujita Health University School of Medicine, 1-98, Kutsukakecho Dengakugakubo, Toyoake City, Aichi, 470-1192, Japan.
Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, 6-1, Kisibesincho, Suita City, Osaka, 564-8565, Japan.
Arthritis Res Ther. 2020 Nov 4;22(1):260. doi: 10.1186/s13075-020-02358-x.
Although the 2018 revised International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification was proposed recently, until now, no reports have been made comparing the association of renal prognosis between the 2018 revised ISN/RPS classification and the 2003 ISN/RPS classification. The present study aimed to assess the usefulness, especially of activity and chronicity assessment, of the 2018 revised ISN/RPS classification for lupus nephritis (LN) in terms of renal prognosis compared to the classification in 2003.
We retrospectively collected medical records of 170 LN patients from the database of renal biopsy at Fujita Health University from January 2003 to April 2019. Each renal biopsy specimen was reevaluated according to both the 2003 ISN/RPS classification and the 2018 revised ISN/RPS classification. Renal endpoint was defined as a 30% decline of estimated glomerular filtration rate (eGFR).
A total of 129 patients were class III/IV±V (class III, 44 patients; class IV, 35 patients; class III/IV+V, 50 patients). The mean age was 42 years, 88% were female, and the median observation period was 50.5 months. Renal prognosis was significantly different among the classes and significantly poor in the patients with higher modified National Institute of Health (mNIH) chronicity index (C index, ≥ 4) by a log-rank test (p = 0.05 and p = 0.02, respectively). By Cox proportional hazard models, only the C index was significantly associated with renal outcome (hazard ratio 1.32, 95% CI 1.11-1.56, p ≤ 0.01), while the classes, the 2003 activity and chronicity subdivision, and the mNIH activity index had no significant association with renal outcome. Each component of the C index was significantly associated with renal outcome in different models.
This study demonstrates that the 2018 revised ISN/RPS classification was more useful in terms of association with renal prognosis compared to the 2003 ISN/RPS classification.
尽管2018年修订的国际肾脏病学会/肾脏病理学会(ISN/RPS)分类最近才被提出,但到目前为止,尚无关于比较2018年修订的ISN/RPS分类与2003年ISN/RPS分类之间肾脏预后相关性的报告。本研究旨在评估2018年修订的ISN/RPS分类在狼疮性肾炎(LN)肾脏预后方面的实用性,尤其是活动度和慢性化评估方面,并与2003年的分类进行比较。
我们回顾性收集了2003年1月至2019年4月期间藤田保健大学肾脏活检数据库中170例LN患者的病历。每个肾脏活检标本均根据2003年ISN/RPS分类和2018年修订的ISN/RPS分类进行重新评估。肾脏终点定义为估计肾小球滤过率(eGFR)下降30%。
共有129例患者为III/IV±V级(III级,44例;IV级,35例;III/IV+V级,50例)。平均年龄为42岁,88%为女性,中位观察期为50.5个月。通过对数秩检验,各分级之间的肾脏预后有显著差异,且改良美国国立卫生研究院(mNIH)慢性化指数(C指数,≥4)较高的患者肾脏预后显著较差(分别为p = 0.05和p = 0.02)。通过Cox比例风险模型,只有C指数与肾脏结局显著相关(风险比1.32,95%置信区间1.11 - 1.56,p≤0.01),而分级、2003年的活动度和慢性化细分以及mNIH活动指数与肾脏结局无显著相关性。在不同模型中,C指数的各个组成部分均与肾脏结局显著相关。
本研究表明,与2003年ISN/RPS分类相比,2018年修订的ISN/RPS分类在与肾脏预后的相关性方面更有用。